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It is our personal practice to utilize the antibiotic-containing
local anaesthetic in all our surgical procedures given that we
routinely perform large numbers of complex reconstructions
at our institution. Individual surgeons may, however, prefer
to reserve the use of intra-incisional antibiotic for higher-risk
groups such as diabetic patients or the elderly or in prolonged
surgical reconstructions. Given the small quantities of antibio-
tic used, coupled with the method of delivery, in our experi-
ence antibiotic resistance has not been a problem.
We have found the use of a buffered lidocaine solution
(with the addition of intra-incisional antibiotic if so desired)
to be safe, convenient and effective during dermatological sur-
gery. We thus describe what we believe to be an efficient,
labour-saving method of preparation. Given the ongoing
financial constraints globally and within the National Health
Service in the U.K., any method of maximizing efficiency and,
as a consequence, productivity (without compromising the
standard of care received by our patients) should be given
careful consideration.
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No major role for glutathione S-transferase
gene polymorphisms in sensitization to
para-phenylenediamine and other xenobiotics:
a study of association and a meta-analysis
DOI: 10.1111/j.1365-2133.2010.10197.x
MADAM, para-Phenylenediamine (PPD), an important contact
allergen, may cause severe allergic contact dermatitis (ACD).
PPD is susceptible to auto-oxidation, resulting in reactive oxy-
gen species (ROS) formation.1 It has been found that oxidative
stress from ROS may play an important role in the sensitiza-
tion phase of ACD to PPD.1 Glutathione S-transferases (GSTs)
are known for their detoxifying role through scavenging
ROS.2 However, human GST genes display polymorphisms
which are likely to contribute to interindividual differences in
responses to xenobiotics.3 By performing an association study
as well as a meta-analysis, we examined the role of GST poly-
morphisms in sensitization to PPD and other xenobiotics.
Entire gene deletion results in the null-alleles GST (theta) T1*0
and GST (mu) M1*0, subsequent absence of enzymatic activity
and therefore, ‘high risk’. For the GST pi-1 gene (GSTP1), a
single nucleotide A to G substitution at position 313 is
known.4 The most common GSTP1*313AA was taken as the
reference allele. To determine a possible synergistic effect, the
combined GSTT1 ⁄GSTM1 genotype was considered. Genotyping
was performed by a real-time polymerase chain reaction
(PCR) assay. The association analysis used a German case–con-
trol set, containing 150 cases and 202 controls. After approval
by the ethics committee, participants gave written informed
consent. For meta-analysis we identified two papers. Wang
et al. (2007) studied sensitization to chromate, whereas West-
phal et al. (2000) examined sensitivity to thimerosal.5,6
Although these studies concern different xenobiotics, we
assumed that they follow the same detoxification pathway.5,6
Including those in our study we analyzed 251 patients with
sensitivity to a xenobiotic (PPD, chromate or thimerosal) and
503 control subjects altogether. GSTT1*0 was significantly
more frequent in controls (22Æ5%) compared with sensitized
subjects (13Æ5%), yielding an odds ratio (OR) of 0Æ54 [95%
confidence interval (CI) 0Æ30–0Æ96, P = 0Æ04] (Table 1).
Neither GSTM1*0, nor GSTT1*0 ⁄GSTM1*0 was significantly
associated with sensitization to PPD (Table 1). GSTP*313 geno-
types were not significantly different in sensitized subjects
compared with controls (Table 1). In the meta-analysis no
significant relationship was found either between GSTT1*0 or
GSTM1*0, or between GSTT1*0 ⁄GSTM1*0 and sensitized sub-
jects (Fig. 1).
Contrary to our a priori hypothesis we observed a protective
effect for GSTT1*0. This finding is in contrast to that reported
by Westphal et al. (2000) and Wang et al. (2007) who
observed GSTT1*0 more frequently in sensitized subjects.5,6 To
accommodate this variation across different studies, we per-
formed a meta-analysis, which found no association of
GSTT1*0 and sensitization overall (Fig. 1). For GSTM1*0, both
we and Wang et al. (2007)5 found no association with sensiti-
zation (Table 1). In contrast, Westphal et al. (2000)6 found
GSTM1*0 significantly more frequent among sensitized sub-
jects. Meta-analysis of all three studies found no difference in
the frequency of GSTM1*0 between sensitized subjects and
controls (Fig. 1). Our association study on the GSTP1 poly-
morphism and sensitization to PPD yielded no statistical
relationship (Table 1); possibly due to the controls deviating
slightly from Hardy–Weinberg equilibrium (HWE) (P =
0Æ02). For ‘high-risk’ profiled patients, i.e. GSTT1*0 ⁄GSTM1*0
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Table 1 Association between the glutathione
S-transferase theta-1 (GSTT1), mu-1 (GSTM1),
combined GSTT1 ⁄GSTM1 and GST pi-1 (GSTP1)
polymorphisms and para-phenylenediamine
(PPD)-sensitized subjects and controls
Genotype
Sensitized subjectsa
n = 141b (%)
Controls
n = 200b (%) OR (95% CI)
GSTT1c Present 122 (86Æ5) 155 (77Æ5) 1 (referent)
Absent 19 (13Æ5) 45 (22Æ5) 0Æ54 (0Æ30–0Æ96)e
GSTM1c Present 74 (52Æ2) 105 (52Æ2) 1 (referent)
Absent 67 (47Æ5) 95 (47Æ5) 1Æ00 (0Æ65–1Æ54)
GSTT1 ⁄GSTM1c Present ⁄present 65 (46Æ1) 81 (40Æ5) 1 (referent)
Absent ⁄present 9 (6Æ4) 24 (12Æ0) 0Æ46 (0Æ20–1Æ08)
Present ⁄absent 57 (40Æ4) 74 (37Æ1) 0Æ95 (0Æ60–1Æ54)
Absent ⁄absent 10 (7Æ1) 21 (10Æ5) 0Æ59 (0Æ26–1Æ35)
GSTP1d Ile-Ile 65 (46Æ4) 87 (47Æ0) 1 (referent)
Ile-Val 57 (40Æ7) 69 (37Æ3) 1Æ11 (0Æ69–1Æ78)
Val-Val 18 (12Æ9) 29 (15Æ7) 0Æ83 (0Æ43–1Æ62)
CI, confidence interval; OR, odds ratio. aSensitization was determined by patch testing;
reading was performed according to the International Contact Dermatitis Research Group
(ICDRG) guidelines. bThe GSTP1 genotype has been genotyped successfully in 140 sensi-
tized subjects and 185 controls. c‘Present’ represents the homozygous reference genotype
(i.e. carriers), ‘absent’ represents the homozygous deleted genotype (i.e. noncarriers).
d‘Ile-Ile’ represents the GSTP1*313AA genotype, ‘Ile-Val’ represents the GSTP1*313AG




Fig 1. Meta-analysis: effect of glutathione S-transferase theta-1-null (GSTT1*0), mu-1-null (GSTM1*0) and combined GSTT1*0 ⁄GSTM1*0 genotypes
on sensitization to xenobiotics. Single odds ratios (ORs) of the three studies involved as well as the total (i.e. pooled) ORs and the overall effect
(Z-test) are shown. The 95% confidence interval (CI) of the pooled ORs was estimated using a Mantel–Haenszel (M–H) random effects model;
heterogeneity among studies was calculated using s2, v2 and I2 tests; all implemented in Review Manager, version 5.0 (The Nordic Cochrane
Centre, The Cochrane Collaboration, Copenhagen, Denmark). A P-value < 0Æ05 was considered statistically significant. (a) GSTT1*0 was considered
the risk allele. (b) GSTM1*0 was considered the risk allele. (c) The GSTT1+ ⁄GSTM1+ (i.e. combined presence) genotype was used as a reference.
The GSTT1*0 ⁄GSTM1*0 (i.e. combined deletion) was considered the highest risk group. *Wang et al. (2007) did not report the combined genotype
in their paper, but provided their raw data upon request. aNumber of carriers of the high-risk allele. bTotal number of sensitized subjects or
controls. cNumber of sensitized subjects within the high-risk group. dTotal number of subjects in the high-risk group. eNumber of sensitized
subjects within the reference group. fTotal number of subjects in the reference group.
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carriers, we found no association with sensitization to PPD
(Table 1). Contrarily, analysis of the data of Wang et al.
(2007) did show a significant effect of the combined deletion,
as did that of Westphal et al. (2000). In conclusion, the
current data have not shown a synergistic effect of
GSTT1*0 ⁄GSTM1*0 in predisposition to sensitization. The dis-
crepancy found in our association analysis cannot be explained
thus far. However, especially given the borderline significant
association for GSTT1*0, additional studies with a larger sam-
ple size might help. The very different findings between our
study and the other two studies can possibly be explained by
the fact that detoxification of the different xenobiotics might
be dependent on additional factors and hence cannot solely be
attributed to the examined GST genes. In fact, this is true for
PPD which is known also to be acetylated by N-acetyltrans-
ferases.7 Moreover, major ethnic differences in frequency
distributions of the GST deletions exist, which may at least
account for the considerable difference found between our
study and Wang’s, as GSTT1*0 is found most frequently in East
Asia.8 One limitation of our study is a possible misclassi-
fication due to the genotyping assay applied which only
discriminated between carriers and noncarriers, while a rele-
vant gene-dosage effect has been described.8 Also, the previ-
ously described linkage disequilibrium between GSTT1 and
GSTT2B polymorphisms in Caucasians, may have had a con-
founding effect.9 Therefore, it may be necessary to evaluate
the GSTT2B polymorphism in order to assess accurately the
associations between GSTT1*0 and sensitization. Like our
results, meta-analysis of relationships between GST polymor-
phisms and cancers often yielded inconsistent and conflicting
results.10 Furthermore, GST genes have been suggested to have
disease-modifying rather than disease-causing effects with a
weak biological impact.4 This might explain the lack of associ-
ation found in sensitization studies. In conclusion, our data as
well as others suggest that the common genetic polymor-
phisms in GSTs may not play a major role in predisposition to
sensitization.
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Treatment of cutaneous sarcoid with topical
gel psoralen and ultraviolet A
DOI: 10.1111/j.1365-2133.2010.10175.x
MADAM, Cutaneous manifestations of sarcoidosis occur in 25–
30% of patients and are typically difficult to manage. Sarcoid
commonly presents as reddish-brown papules, nodules or pla-
ques. The pathognomonic lesion is lupus pernio, a variant that
is more prevalent in Afro-Caribbean subjects, tends to persist
and results in significant facial disfigurement. Less common
presentations include hypopigmentation, subcutaneous
nodules, alopecia and ulceration.
We report a series of six patients with cutaneous sarcoid
successfully treated with topical gel psoralen and ultraviolet A
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